Erlotinib complexation with randomly methylated β-cyclodextrin improves drug solubility, intestinal permeability, and therapeutic efficacy in non-small cell lung cancer-Reference-Cited by-同舟云学术

Erlotinib complexation with randomly methylated β-cyclodextrin improves drug solubility, intestinal permeability, and therapeutic efficacy in non-small cell lung cancer

Published:2021-07-05 Issue:7 Volume:26 Page:797-806
ISSN:1083-7450
Container-title:Pharmaceutical Development and Technology
language:en
Short-container-title:Pharmaceutical Development and Technology

Author:

Erdoğar Nazlı¹,Akkın Safiye¹,Varan Gamze¹,Bilensoy Erem¹

Affiliation:

1. Department of Pharmaceutical Technology, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/10837450.2021.1946695

Reference47 articles.

1. Evaluation of Buccal Methyl-β-Cyclodextrin Toxicity on Human Oral Epithelial Cell Culture Model

2. Cyclodextrin–Drug Inclusion Complexes: In Vivo and In Vitro Approaches

3. Cholesterol and Its Metabolites in Tumor Growth: Therapeutic Potential of Statins in Cancer Treatment

4. The Stability of Cyclodextrin Complexes in Solution

5. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico , in vitro and in vivo evaluation

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. QbD assisted development of inhalable spray-dried erlotinib procubosomal system for the effective management of non-small cell lung cancer;Journal of Drug Delivery Science and Technology;2023-12

2. Receptor-Mediated Targeting in Breast Cancer through Solid Lipid Nanoparticles and Its Mechanism;Current Drug Metabolism;2022-08

3. Research and Development of Supramolecules as Anticancer Drugs;Pharmaceutical Applications of Supramolecules;2022